Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma
Tongxin Liu(Southern Medical University), Wei Wang(Southern Medical University)
Cited by 83
Related Papers
EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
|Molecular Cancer|2019|316